Immunohistochemical expression of survivin and γ-H2AX in vulvar intraepithelial neoplasia and low-stage squamous cell carcinoma

International Journal of Gynecological Pathology

Volumn 30, Issue 6, 2011, Pages 583-590

  Brustmann, Hermann ^a   Hinterholzer, Susanne ^b   Brunner, Andreas ^b  

^a Departments of Pathology   (Austria)

^b Departments of Obstetrics and Gynecology   (Austria)

Author keywords

H2AX; Apoptosis; Neoplasia; Survivin; Vulva

Indexed keywords

DNA; FORMALDEHYDE; HISTONE H2AX; PARAFFIN; SURVIVIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER STAGING; CELL CYCLE REGULATION; CELLULAR DISTRIBUTION; DNA DAMAGE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LICHEN SCLEROSUS ET ATROPHICUS; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; PRECURSOR; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; VAGINAL INTRAEPITHELIAL NEOPLASIA; VULVAR INTRAEPITHELIAL NEOPLASIA;

CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; FEMALE; HISTONES; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITOR OF APOPTOSIS PROTEINS; NEOPLASM GRADING; NEOPLASM STAGING; TUMOR MARKERS, BIOLOGICAL; VULVAR NEOPLASMS;

EID: 80053947866     PISSN: 02771691     EISSN: 15387151     Source Type: Journal    
DOI: 10.1097/PGP.0b013e31821e18fd     Document Type: Article

References (35)

1. Hart WR. Vulvar intraepithelial neoplasia: historical aspects and current status. Int J Gynecol Pathol 2001;20:16-30. (Pubitemid 32041755)
2. Lerma E, Matias-Guiu X, Lee SJ, et al. Squamous cell carcinoma of the vulva: study of ploidy, HPV, p53, and pRb. Int J Gynecol Pathol 1999;18:191-7. (Pubitemid 29306973)
3. Clement PB, Young RH. Malignant tumors of the vulva. In: Bordin GM, ed. Atlas of Gynecologic Surgical Pathology. Philadelphia: Saunders; 2000:22-7.
4. Prat J. Pathology of vulvar intraepithelial lesions and early invasive carcinoma. Hum Pathol 1991;22:877-83.
5. Haefner HK, Tate JE, McLachlin CM, et al. Vulvar intraepithelial neoplasia: age, morphological phenotype, pa-pillomavirus DNA, and coexisting invasive carcinoma. Hum Pathol 1995;26:147-54.
6. Toki T, Kurman RJ, Park JS, et al. Probable nonpapilloma-virus etiology of squamous cell carcinoma of the vulva in older women: a clinicopathologic study using in situ hybridization and polymerase chain reaction. Int J Gynecol Pathol 1991;10: 107-25.
7. Johnson ME, Howerth EW. Survivin: a bifunctional inhibitor of apoptosis protein. Vet Pathol 2004;41:599-607. (Pubitemid 39573750)
8. Altieri D. The case for survivin as a regulator of microtubule dynamics and cell-death decisions. Cur Opin Cell Biol 2006;18:609-15. (Pubitemid 44692469)
9. Peroukides S, Bravou V, Alexopoulos A, et al. Survivin overexpression in HCC and liver cirrhosis differentially correlates with p-STAT3 and E-cadherin. Histol Histopathol 2010;25:299-307.
10. Adida C, Crotty P, McGrath J, et al. Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am J Pathol 1998;152:43-9. (Pubitemid 28028045)
11. Kim PJ, Plescia J, Clevers H, et al. Survivin and molecular pathogenesis of colorectal cancer. Lancet 2003;362:205-9. (Pubitemid 36859937)
12. Blanc-Brude O, Mesri M, Wall N, et al. Therapeutic targeting of the survivin pathway in cancer: Initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis. Clin Cancer Res 2003;9:2683-92. (Pubitemid 36842114)
13. Li F, Yang J, Ramnath N, et al. Nuclear or cytoplasmic expression of survivin: what is the significance? Int J Cancer 2005;114:509-12. (Pubitemid 40349608)
14. Altieri D. Validating survivin as a cancer therapeutic target. Nat Rev 2003;3:46-54. (Pubitemid 37328886)
15. Li F. Survivin study: what is the next wave? J Cell Physiol 2003;197:8-29. (Pubitemid 37486223)
16. Wang J, Yang L, Yang J, et al. Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3 kinase/AKT/survivin pathway in colon cancer cells. Cancer Res 2008;68:3152-60.
17. Zhang T, Olevrel T, Gao Z, et al. Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res 2001; 62:8664-7. (Pubitemid 34013874)
18. Mirza A, McGuirk M, Hockenberry T, et al. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependant apoptotic pathway. Oncogene 2002;21:2613-22. (Pubitemid 34478319)
19. Thiriet C, Hayes JJ. Chromatin in need of a fix: phosphorylation of H2AX connects chromatin to repair. Molecular Cell 2005;18:617-22. (Pubitemid 40804798)
20. Brustmann H, Hinterholzer S, Brunner A. Expression of phosphorylated histone H2AX (c-H2AX) in normal and neoplastic squamous epithelia of the uterine cervix: an immunohistochemical study with epidermal growth factor receptor (EGFR). Int J Gynecol Pathol 2011;30:76-83.
21. Rogakou EP, Nieves-Neira W, Boon C, et al. Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139. J Biol Chem 2000;275:9390-5. (Pubitemid 30185164)
22. Hacker N. Revised FIGO staging for carcinoma of the vulva. Int J Gynecol Obstet 2009;105:105-6.
23. Brustmann H, Naude S. Expression of topoisomerase IIa, Ki-67, proliferating cell nuclear antigen, p53, and argyrophilic nucleolar organizer regions in vulvar squamous lesions. Gynecol Oncol 2002;86:192-9. (Pubitemid 34953504)
24. Lo Muzio L, Pannone G, Staibano S, et al. Survivin expression in oral squamous cell carcinoma. Br J Cancer 2003;89:2244-8. (Pubitemid 38168006)
25. Branca M, Giorgi C, Santini D, et al. Survivin as a marker of cervical intraepithelial neoplasia and high-risk human papillomavirus and a predictor of virus clearance and prognosis in cervical cancer. Am J Clin Pathol 2005;124:113-21. (Pubitemid 40944383)
26. Altieri DC. Survivin and IAP proteins in cell death mechanisms. Biochem J 2010;430:199-205.
27. Liu X, Gao R, Dong Y, et al. Survivin gene silencing sensitizes prostate cancer cells to selenium growth inhibition. BMC Cancer 2010;10:418.
28. Wasco MJ, Pu RT, Yu L, et al. Expression of c-H2AX in melanocytic lesions. Hum Pathol 2008;39:1614-20.
29. Bartkova J, Horejsi Z, Koek K, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 2005;434:864-70. (Pubitemid 40558993)
30. Gorgoulis VG, Vassiliou LV, Karakaidos P, et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 2005;435:907-13. (Pubitemid 40559004)
31. Ueda Y, Enomoto T, Kimura T, et al. Two distinct pathways to development of squamous cell carcinoma of the vulva. J Skin Cancer 2011;2011:951250.
32. Kuo LJ, Yang LX. Gamma-H2AX-a novel biomarker for DNA double-strand breaks. In vivo 2008;22:305-9.
33. Bonner WM, Redon CE, Dickey JS, et al. GammaH2AX and cancer. Nat Rev Cancer 2008;8:957-67.
34. Munshi A, Kurland JF, Nishikawa T, et al. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity. Clin Cancer Res 2005;11:4912-22. (Pubitemid 41557212)
35. Solier S, Pommier Y. The apoptotic ring. Cell Cycle 2009;8:1853-9.